calquence
astrazeneca ab - acalabrutinib - leukemija, limfocitna, kronična, b-stanica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
dasatinib zentiva 140 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 140 mg - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba
dasatinib zentiva 50 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba
dasatinib zentiva 70 mg filmom obložene tablete
zentiva k.s., u kabelovny 130, dolni mecholupy, prag 10, Češka - дазатиниб - filmom obložena tableta - 70 mg - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba
nodriga 100 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba
nodriga 140 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba
nodriga 20 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba
nodriga 50 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba
nodriga 70 mg filmom obložene tablete
alkaloid - int d.o.o., Šlandrova ulica 4, ljubljana - Črnuče, slovenija - дазатиниб - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.